ADHD

Alcobra Ltd. Press Releases

$18.87
*  
0.27
1.45%
Get ADHD Alerts
*Delayed - data as of Jul. 11, 2014  -  Find a broker to begin trading ADHD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Alcobra to Host Investor Forum and Webcast on July 15 in New York City
7/7/2014 8:00:00 AM - GlobeNewswire

Alcobra Ltd. to Provide Corporate Overview at the JMP Securities Healthcare Conference
6/17/2014 8:00:00 AM - GlobeNewswire

Alcobra to Present at the American Society of Clinical Psychopharmacology Annual Meeting and the BIO International Convention
6/9/2014 8:00:00 AM - GlobeNewswire

Alcobra Ltd. to Provide Corporate Overview at the Jefferies 2014 Global Healthcare Conference
5/27/2014 8:00:00 AM - GlobeNewswire

Alcobra Ltd. to Present at the Gordon Research Conference on Fragile X and Autism-Related Disorders
5/23/2014 8:00:00 AM - GlobeNewswire

Alcobra Announces First Quarter Financial Results and Corporate Update
5/15/2014 7:30:00 AM - GlobeNewswire

Alcobra Ltd. Presents Evidence of Novel Mechanism of Action for Metadoxine Extended Release (MDX) in Cognitive Disorders at the Society of Biological Psychiatry Annual Meeting
5/12/2014 8:00:00 AM - GlobeNewswire

Alcobra Announces FDA Clearance of Protocol for Phase IIb Study of Metadoxine Extended Release (MDX) in the Treatment of Fragile X Syndrome
5/8/2014 12:20:00 PM - GlobeNewswire

Alcobra Ltd. to Provide Corporate Overview at Oppenheimer and BioMed Conferences
5/8/2014 8:00:00 AM - GlobeNewswire

Alcobra Ltd. to Release First Quarter 2014 Results and Host Investor Conference Call on Thursday, May 15, 2014
5/7/2014 4:05:00 PM - GlobeNewswire

Alcobra Ltd. Presents Positive Results From Phase IIb Study of Metadoxine Extended Release (MDX) in Adults With Predominantly Inattentive ADHD at APA Annual Meeting
5/5/2014 8:00:00 AM - GlobeNewswire

Alcobra Issued New US Patent Covering Metadoxine Use for Cognitive Disorders
5/1/2014 8:00:00 AM - GlobeNewswire

Alcobra Ltd. to Present New Data for Metadoxine Extended Release (MDX) at Upcoming Meetings
4/24/2014 8:00:00 AM - GlobeNewswire